Please enter the email address you used to register, then we will send you a link to choose a new password
Exclusive rights to universal CAR technology platform designed to target multiple antigens simultaneously, recently expanded to...
The Dow Jones index closed lower by around 100 points on Wednesday. When insiders purchase or sell shares, it indicates their c...
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) (the "Company" or "Coeptis"), a biopharmaceutical company dev...
Poster presentation describes the development of SNAP CAR platform technology as a "universal" CAR therapy with the po...
This amended agreement builds upon the original exclusive license agreement with the University of Pittsburgh for SNAP-CAR T-Ce...
Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and ann...
Coeptis Expects To Report Topline Safety And Efficacy Data From The Full Patient Population In Q1 Of 2024